This project proposes an innovative multinuclear MRI approach to gain mechanistic insight into the exercise- associated adaptations in lower leg muscle function and peripheral nerve integrity of patients with diabetic peripheral neuropathy (DPN). A significant consequence of DPN is loss of peripheral nerve integrity, neurogenic muscle atrophy, fatty infiltration, and loss of muscle endurance. These synergistically contribute to altered gait, impaired balance, and increased fall risk, which can lead to bone fractures, poorly healing wounds, and chronic infections that often require an amputation. There are no therapies to prevent or reverse the progress of DPN. Preliminary single-group studies showed that a 10-week moderate-intensity supervised exercise program is well tolerated by patients with DPN, and improves nerve function, cutaneous innervation, and cardiovascular and macrovascular endothelial functions. However, the physiological basis of these effects is poorly defined. Our team is uniquely positioned to use novel multinuclear MRI technology to understand how exercise affects skeletal muscle and peripheral nerve integrity and function in patients with DPN. We will prescribe a 10-week exercise program, with both aerobic and strengthening components, to 50 DPN patients who will receive personal supervision from health professionals. Another 50 DPN patients will be randomly assigned to the non-exercising control group. We hypothesize that i) exercise will improve peripheral nerve integrity (fractional anisotropy will increase, and the apparent diffusion coefficient will decrease as measured using diffusion tensor imaging), ii) exercise will decrease plasma levels of oxidative stress, iii) exercise will improve DPN symptoms, assessed with the Michigan Neuropathy Screening Instrument.
Our second aim i s to determine the effect of exercise on lower leg muscle structure and function in DPN patients. We hypothesize that i) exercise will increase leg mitochondrial function, as defined by an increase in oxidative capacity (measured using phosphorus-MRI), ii) exercise will improve leg microvascular function, as defined by an increase in peak microvascular response (measured using BOLD-MRI), and iii) exercise will decrease intramuscular fat and increase levels of fat-free muscle (measured using IDEAL-MRI). Advanced multinuclear- MRI can provide mechanistic insight into exercise-related adaptations in patients with DPN. These include changes in intramuscular fat content, MV and metabolic functions of the skeletal muscle, as well as peripheral nerve function and integrity. Understanding these adaptations promises to reveal new ways to improve DPN symptoms after exercise interventions, better predict patient outcomes, and develop more effective treatments for DPN.

Public Health Relevance

This project proposes a randomized control trial that uses multinuclear-MRI to evaluate the mechanistic effects of exercise on skeletal muscle function and peripheral nerve integrity in patients with diabetic peripheral neuropathy (DPN), and to determine whether exercise can reverse DPN symptoms. We will prescribe a 10- week exercise program to 50 DPN, while another 50 DPN patients will be randomly assigned to the non- exercising control group. We will acquire multinuclear-MRI data before and after the intervention that can provide mechanistic insight into the adaptations in lower leg muscle function and peripheral nerve integrity of patients with DPN and their role in improving DPN symptoms following physical exercise intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK114428-01A1
Application #
9521257
Study Section
Clinical and Integrative Diabetes and Obesity Study Section (CIDO)
Program Officer
Jones, Teresa L Z
Project Start
2018-07-01
Project End
2020-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
New York University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016